PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19940140-6	2010	We demonstrated that high N-sulfate density and the presence of 2-O- and 3-O-sulfates determine binding of CyPB, as evidenced by competitive experiments with heparin derivatives, soluble HS, and anti-HS antibodies.	Heparin	158-165	peptidylprolyl isomerase B	Homo sapiens	107-111	
17588944-0	2007	The heparin/heparan sulfate sequence that interacts with cyclophilin B contains a 3-O-sulfated N-unsubstituted glucosamine residue.	Heparin	4-11	peptidylprolyl isomerase B	Homo sapiens	57-70	
15109301-0	2004	Octasaccharide is the minimal length unit required for efficient binding of cyclophilin B to heparin and cell surface heparan sulphate.	Heparin	93-100	peptidylprolyl isomerase B	Homo sapiens	76-89	
15109301-8	2004	We then demonstrated that heparin-derived octasaccharides and higher degree of polymerization oligosaccharides inhibited the interaction between CyPB and fluorophore-labelled HS chains purified from T-lymphocytes, and strongly reduced the HS-dependent pro-adhesive activity of CyPB.	Heparin	26-33	peptidylprolyl isomerase B	Homo sapiens	145-149	
15109301-8	2004	We then demonstrated that heparin-derived octasaccharides and higher degree of polymerization oligosaccharides inhibited the interaction between CyPB and fluorophore-labelled HS chains purified from T-lymphocytes, and strongly reduced the HS-dependent pro-adhesive activity of CyPB.	Heparin	26-33	peptidylprolyl isomerase B	Homo sapiens	277-281	
9841882-5	1998	We first provide evidence that the CyPB binding to heparin-Sepharose is prevented by soluble sulphated glycosaminoglycans (GAG), raising the interesting possibility that such interactions may occur on the T-cell surface.	Heparin	51-58	peptidylprolyl isomerase B	Homo sapiens	35-39